PhAMA represents 41 of the biggest names in biopharmaceuticals. Within that scope, its professional collective includes people from regulatory, research and development (R&D), medical expertise, finance, information technology, human resources, legal and compliance, as well as logistics and ethical marketing.
More importantly, PhAMA brings together invaluable experience in coordinating with global and local authorities.
50 years of service allows the Association to lead with a focus on Industry Support , Strategic Partnerships, Advocacy, and Capacity Building in driving access to innovative medicines for Malaysia.
A further 50 years, PhAMA will continue to drive patient-centred progress in innovation, affordability and access to life-saving medicines and contribute to a better healthcare system in Malaysia. Click here for PhAMA Rules & Constitution
is to provide access to innovative medicines for better health and improved quality of life for all in Malaysia.
Advocating for evidence-based medicine and promoting safe, effective and quality use of medicines.
Driving groundbreaking research and development that address current and future healthcare challenges.
Breaking down barriers that hinder patient access, and accelerate the availability of life-saving, innovative medicines for unmet needs.
Maximising our collective impact and driving positive change by fostering collaborations, partnerships and sharing best practices with healthcare stakeholders.
Establishing responsible self-care as an integral part of comprehensive health promotion and disease prevention.
Promoting and upholding the industry values and highest ethical standards while significantly contributing to the nation's healthcare sector.
Actively develop and strengthen the industry's ability to innovate, adapt, and deliver high-quality healthcare solutions for nation building.
Uphold the highest standards of integrity, transparency, and responsibility to ensure the ethical promotion of medicines in strict compliance with local laws and established marketing practices.
Ensure patients are active partners in their healthcare journey, receiving safe, effective, personalized pharmaceutical care that addresses their unique needs and optimise treatment outcome.